PZ0340

PF-06737007

≥98% (HPLC)

• 别名: 2-((3R,4S)-3-Fluoro-1-(2-(4-(trifluoromethoxy)phenyl)acetyl)piperidin-4-yloxy)-4-(2-hydroxy-2-methylpropoxy)benzamide, 2-[[(3R,4S)-3-Fluoro-1-[2-[4-(trifluoromethoxy)phenyl]acetyl]piperidin-4-yl]oxy]-4-(2-hydroxy-2-methylpropoxy)benzamide, PF06737007
• 经验公式（希尔记法）: C₂₅H₂₈F₄N₂O₆
• CAS号: 1863905-38-7
• 分子量: 528.49
• UNSPSC代码: 12352200
• PubChem化学物质编号: 329823849
• NACRES: NA.77

属性

• 质量水平: 100
• 方案: ≥98% (HPLC)
• 表单: powder
• 颜色: white to beige
• 溶解性: DMSO: 25 mg/mL, clear
• 储存温度: room temp
• SMILES字符串: F[C@@H]1CN(C(CC2=CC=C(OC(F)(F)F)C=C2)=O)CC[C@@H]1OC3=C(C(N)=O)C=CC(OCC(C)(C)O)=C3
• InChI key: AUTGNDRENPBZKA-UXHICEINSA-N

说明

生化/生理作用

PF-06737007 is pan tropomyosin-related kinase (Trk) inhibitor.

PF-06737007 is pan tropomyosin-related kinase inhibitor.

其他说明

This compound was developed by Pfizer for Kinase Phosphatase Biology research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.

法律信息

Sold for research purposes under agreement from Pfizer Inc.

安全信息

• 象形图: GHS07
• 警示用语：: Warning
• 危险声明: H315,H319,H335
• 预防措施声明: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• 危险分类: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• 靶器官: Respiratory system
• 储存分类代码: 11 - Combustible Solids
• WGK: WGK 3
• 闪点(°F): Not applicable
• 闪点(°C): Not applicable